According to the FDA, six cases have been detected with severe clotting of blood after the administration of greater than 6.8 million doses of the Johnson & Johnson vaccine.
Individuals under the age of 30 in UK are being offered an alternate vaccine for COVID-19 infection in place of Oxford-AstraZeneca jab due to evidence of formation of rare blood clots.
Rather than providing personal data, a contact tracing app would inform the system when an individual diagnosed with COVID-19 visited any location across the country and scan QR code.
Seven individuals have reportedly died as they soon started developing blood clots after being administered with the AstraZeneca vaccine in the United Kingdom.
According to the European Commission, 40% of the individuals' underemployment across the European Union began to work full time remotely due to the global impact of COVID-19 pandemic.
A new coronavirus variant has been detected in the South Asian country of India, which is said to be a double mutant and has been diagnosed in multiple patients in the country.
Several countries located across the European Union have paused the administration of the AstraZeneca vaccine across their nations, including Spain, Italy, France, and Germany.
Oxford-AstraZeneca vaccine is a highly protective measure against the rapidly surging COVID-19 infection, as it reduces the risk of viral infection and needs treatment from a medical center by 80%.
The pandemic stress has had a huge toll on the essential working staff members, who are working in medical facilities or law enforcement agencies as adapted to unhealthy habits.